These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9519106)

  • 1. Cost-effectiveness of clozapine.
    Kerwin RW; Aitchison KJ
    Br J Psychiatry; 1997 Dec; 171():584. PubMed ID: 9519106
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine and hospitalization.
    Rosenheck R; Charney D; Cramer J
    Psychiatr Serv; 1999 Jan; 50(1):114-6. PubMed ID: 9890595
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of clozapine. A UK clinic-based study.
    Aitchison KJ; Kerwin RW
    Br J Psychiatry; 1997 Aug; 171():125-30. PubMed ID: 9337946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of clozapine therapy for severe psychosis.
    Ghaemi SN; Ziegler DM; Peachey TJ; Goodwin FK
    Psychiatr Serv; 1998 Jun; 49(6):829-31. PubMed ID: 9634167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness of Antipsychotics in the Maintenance Treatment of Schizophrenia in Colombia].
    Quitian Reyes H; Arciniegas Barrera JA; Bohórquez Peñaranda A; Gómez Restrepo C
    Rev Colomb Psiquiatr; 2016; 45(2):67-74. PubMed ID: 27132755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomics of antipsychotic drug therapy.
    Hargreaves WA; Shumway M
    J Clin Psychiatry; 1996; 57 Suppl 9():66-76. PubMed ID: 8823354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel.
    Ginsberg G; Shani S; Lev B
    Pharmacoeconomics; 1998 Feb; 13(2):231-41. PubMed ID: 10178649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugs.
    Rosenheck R; Doyle J; Leslie D; Fontana A
    Schizophr Bull; 2003; 29(1):81-93. PubMed ID: 12908663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacoeconomics of clozapine: a review.
    Meltzer HY; Cola PA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New vs. old antipsychotics: the Texas experience.
    Reid WH
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental health. Special agents.
    Bryan J
    Health Serv J; 1999 Jan; 109(5639):suppl 4-6. PubMed ID: 10345647
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
    Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR
    Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW; Malan RD
    J Clin Psychiatry; 1999; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
    Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H
    Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
    Lieberman JA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
    [No Abstract]   [Full Text] [Related]  

  • 17. Looking beyond the formulary budget in cost-benefit analysis.
    Cohen LJ
    Am J Manag Care; 1997 Feb; 3 Suppl():S11-7. PubMed ID: 10180337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study.
    Hayhurst KP; Brown P; Lewis SW
    J Psychopharmacol; 2002 Jun; 16(2):169-75. PubMed ID: 12095076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
    Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial-based cost-effectiveness analyses of antipsychotic use.
    Polsky D; Doshi JA; Bauer MS; Glick HA
    Am J Psychiatry; 2006 Dec; 163(12):2047-56. PubMed ID: 17151153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.